Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04379388 · ClinicalTrials.gov registry record · NA
Improving Smoking Cessation in Socioeconomically-Disadvantaged Young Adults
A NA study of Nicotine Dependence, Cigarettes, sponsored by University of Vermont.
- Completed
- Registry status
- NA
- Development phase
- 437
- Enrollment target
- 1
- Study location
NCT04379388: Completed NA study of Nicotine Dependence, Cigarettes, sponsored by University of Vermont.
NCT04379388 is a NA study of Nicotine Dependence, Cigarettes that has completed, run by University of Vermont. The registered enrollment target is 437 participants, above the 100-participant average among 3 other Nicotine Dependence, Cigarettes trials with a reported enrollment target (337% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04379388, a NA study of Nicotine Dependence, Cigarettes, has completed, sponsored by University of Vermont.
- COMPLETED
- Registry status
- NA
- Development phase
- 437 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to understand how to develop and deliver a better smoking cessation program for lower-income young adult smokers.
Primary Outcome
Self-reported smoking abstinence and biochemical validation (saliva cotinine)
Conditions Studied
Interventions
- BEHAVIORAL Web + text smoking cessation intervention
Study Locations (1)
Vermont
- University of Vermont - Burlington
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 437 participants |
| Start Date | 2020-04-21 |
| Est. Completion | 2020-10-15 |
| Phase | NA |
What the finished NCT04379388 record still lists
NCT04379388 is an interventional study that assigns participants to a tested intervention. The registered 437 participants enrollment target is mid-sized for trials with a published cap, above the 100-participant average among 3 other Nicotine Dependence, Cigarettes trials with a reported enrollment target (337% higher).
The record links to 1 condition, with Nicotine Dependence, Cigarettes appearing as the primary indexed condition, and to 1 intervention - of which Web + text smoking cessation intervention is the first listed.
NCT04379388 reports a single indexed study location in Vermont.
Frequently Asked Questions
What is clinical trial NCT04379388 about?
NCT04379388 is a clinical study titled "Improving Smoking Cessation in Socioeconomically-Disadvantaged Young Adults". The purpose of this study is to understand how to develop and deliver a better smoking cessation program for lower-income young adult smokers.
What is the current status of trial NCT04379388?
This trial is currently completed. It is a NA study. The enrollment target is 437 participants. The study started on 2020-04-21. Estimated completion is 2020-10-15.
What conditions does trial NCT04379388 study?
This clinical trial studies the following conditions: Nicotine Dependence, Cigarettes.
What interventions are being tested in trial NCT04379388?
The interventions under investigation include: Web + text smoking cessation intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT04379388?
This trial is sponsored by University of Vermont, which has 162 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04379388 being conducted?
This trial has 1 study location across Vermont. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Nicotine Dependence, Cigarettes
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05711446 · 438 participants · NA
Double Voiding and Post-transplant UTI
- NCT02622542 · 436 participants · NA
ACute Uncomplicated Type b Aortic Dissection: Endovascular Repair vs. Best Medical Therapy
- NCT05918211 · 436 participants · Phase 3
Fontan Udenafil Exercise Longitudinal Assessment Trial - 2
- NCT06966479 · 436 participants · Phase 2
A Long-Term Safety and Efficacy Study of Verekitug (UPB-101) in Adult Participants With Severe Asthma (VALOUR)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI